π¬ CellVec's new in-house Quality Control lab ensures the safety and efficacy of our advanced cell and gene therapies. This is a major step towards accelerating the development of life-changing treatments. #QualityControl#GeneTherapy#PatientSafety
At CellVec, meticulous GDP documentation fuels our work from R&D to QC, ensuring safe, effective products. We invest in SOPs, training, and continuous improvement because we know reliable documentation is crucial. #Pharma#GDP#QualityControl
@CellVec is committed to advancing women in medicine. We're proud that 53% of our employees & leadership roles are held by women, exceeding the STEM average. Let's #InvestInWomen to drive innovation and improve healthcare outcomes. #InternationalWomensDay#WomenInSTEM
Projected to hit $80B by 2029, the #CellandGeneTherapy market leads pharmaceutical trends, outpacing precision medicine.
Challenges like high costs & trial risks persist, but for viral vector CDMOs, it's a chance to innovate & globalize production.
#Innovation#Healthcare
A Happy Lunar New Year from all of us at CellVec! πβ¨Our office is looking auspicious and festive with our newest decorations to match the bountiful spirit!
Here's to a Lunar New Year filled with health, innovation and strength. #CNY2024#CellVec
Thank you to @ISCTglobal for nominating Dr. Gayatri Sharma to the APAC Industry Committee. We're looking forward to further contributing to advancing #CellAndGeneTherapy innovations through this milestone. π
See you at #ISCT2024! Follow us for more exciting news ahead.
We're Excited for 2024! And here's why:
We'll be at the @ASGCTherapy Annual Meeting in Baltimore and the @ISCTglobal Annual Meeting in Vancouver this year.
We're also aiming for a +150% in our production capacity for cell and gene therapy to meet the growing #BioTech demands.
Congratulations to Dr. Anushree on winning this year's Long Service Award! In her 5 years at CellVec, Dr. Anushreee has been a fantastic leader whom all her colleagues know they can count on. #LongServiceAward#CellVec
Today marks our 2-year anniversary with Peter MacCallum Cancer Centre. We're proud to supply essential GMP lentiviral vectors, expedite project timelines, and contribute to life-changing therapies. #CancerResearch#Innovation
π CellVec's Annual Dinner and Dance at Grand Copthorne Waterfront was a blast! π Thanks to our amazing team for a fantastic year. #CellVec#TeamCelebration#CheersToTeamwork
𧬠Dr. Steven Oh and Mr Tan Wee Jin of #CellVec were at the ISCT ANZ 2023 where they discovered the latest advances in cell and #geneTherapy, particularly the use of specialized CARs that could target T-cells more effectively. The continuing growth of CGT is one to watch!
𧬠Gene therapy's promise hinges on vector design: both efficient & safe. Dr. Paula Lam of CellVec emphasises Jesse Gelsinger's tragedy and says good vector design is paramount. Innovation + high safety standards will produce breakthroughs that change lives. CellVec π§ͺ
#CellVec
This National Day, we want to thank our stakeholders for their support enabling us to achieve remarkable breakthroughs in gene therapy manufacturing.
And to our nation #Singapore, for providing an environment to innovate, grow and contribute to advances in healthcare.
#CellVec
At CellVec, we adhere to stringent process design, validation + testing, empowering clients to create solutions that transform therapeutic ideas into clinical practice using vectors designed and built for translational and commercial gene therapy.
#CellVec#CDMO
At CellVec we pride ourselves on understanding the latest requirements and phase-appropriate expectations on good manufacturing practice for a successful investigational new drug (IND) process for our sponsors. Reach out for assistance on your IND journey.
#CellVec#CDMO
We facilitate the advancement of our clientβs products from bench-to-bedside for clinical applications. Partnering with a CDMO with a good quality manufacturing system makes a difference, reducing cost and timelines to production.
Learn more at: https://t.co/cUwEM758wS
#CellVec